Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Selma: The Complete Guide for Women, Families, and Survivors
For women in City of Selma who have undergone breast reconstruction, revision, or aesthetic surgery, the expectation was a path toward healing, confidence, and restoration. Whether you were recovering from a mastectomy at a major San Antonio-area medical center or seeking a cosmetic lift in a private surgical suite near the I-35 corridor, you trusted the materials placed inside your body. You trusted that the surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffold reinforcement was thoroughly tested and specifically approved for use in human breast tissue.
The reality we now know is far more troubling. As of our most recent investigation into the medical device landscape, the U.S. Food and Drug Administration (FDA) has explicitly stated that no surgical mesh products have been cleared or approved by the agency for use in breast surgery. Thousands of women in City of Selma and throughout Bexar County may have been implanted with devices like GalaFLEX, Phasix, AlloMax, or FlexHD—products often marketed off-label for “internal bra” techniques or lower-pole reinforcement—without being warned of the significant risks of infection, reconstruction failure, or even rare forms of cancer.
At The Manginello Law Firm, PLLC—operating under our consumer brand Attorney911—we represent women in City of Selma who are facing the devastating physical and emotional consequences of defective breast-applied devices. Our Managing Partner, Ralph P. Manginello, has been licensed by the State Bar of Texas since 1998 (Bar Card No. 24007597) and brings twenty-seven years of continuous practice to these complex litigations. Along with Associate Attorney Lupe Peña, who conducts full client consultations in fluent Spanish, our firm is admitted to the United States District Court for the Southern District of Texas and handles high-profile institutional liability cases throughout the state. We recently filed the $10,000,000 Bermudez v. Pi Kappa Phi litigation in Harris County, demonstrating our capability to prosecute cases against massive corporate and institutional defendants.
If you are a resident of City of Selma dealing with an unexplained infection, a failed reconstruction, or a recent diagnosis of BIA-ALCL or BIA-SCC, you are not just a statistic. You are a neighbor in our community, and we are here to provide the substantive legal and medical education you deserve. You can reach us 24/7 at 1-888-ATTY-911 for a confidential, no-obligation conversation.
Understanding the Devices: Mesh, ADM, and Scaffolds Used in City of Selma Surgeries
To understand your legal options in City of Selma, it is essential to first identify the three primary categories of devices frequently used off-label in breast procedures. While these materials are often used interchangeably in surgical discussions, they have distinct biological and chemical profiles that dictate how they interact with your tissue and how they may fail.
Acellular Dermal Matrix (ADM)
Acellular Dermal Matrix is a biologic material derived from human cadaver skin or animal tissue (porcine or bovine). In the decellularization process, the manufacturer removes the cells that would cause an immune rejection, leaving behind a collagen scaffold meant to integrate with your body’s own cells. For a patient in City of Selma, this was likely described as a “hammock” to support an implant or tissue expander. Common brands include:
- AlloDerm and AlloDerm RTU: Manufactured by Allergan (now AbbVie), this is the most widely used ADM in U.S. reconstructions.
- FlexHD and FlexHD Pliable: Manufactured by MTF Biologics, specifically named by the FDA for its higher-than-average complication rates.
- AlloMax: A C.R. Bard/Becton Dickinson (BD) product also flagged by the FDA for elevated infection and reoperation risks.
- Strattice: A porcine-derived matrix from Allergan, frequently used in complex revisions.
Bioabsorbable and Resorbable Scaffolds
Unlike permanent synthetic mesh, these materials are designed to provide temporary support and then slowly dissolve as your body replaces them with natural scar tissue. The primary material used here is poly-4-hydroxybutyrate (P4HB), a polymer that undergoes a process called hydrolysis—breaking down into water and carbon dioxide.
In City of Selma and the surrounding Bexar County medical hubs, the dominant scaffold is GalaFLEX (manufactured by Tepha/Galatea and now owned by Becton Dickinson). Other P4HB products include Phasix Mesh, which was originally cleared for hernia repair but is frequently used off-label in breast surgery. The danger for City of Selma patients lies in the scaffold failing to resorb on the manufacturer’s stated 18-to-24-month timeline, leading to palpable edges, inflammation, and chronic pain years after the surgery.
Synthetic Surgical Mesh
General synthetic mesh, often made of polypropylene, was never intended for the delicate environment of breast tissue. When used off-label in City of Selma, these permanent synthetics carry the highest risk of erosion, where the mesh literally wears through the skin or the implant, causing catastrophic disfigurement and requiring multiple salvage surgeries.
The 510(k) Pathway: A Regulatory Failure Affecting City of Selma Patients
Many women in City of Selma are shocked to learn that the devices inside them were never clinically tested for breast surgery. This is due to the FDA’s 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a manufacturer can bring a device to market by simply claiming it is “substantially equivalent” to a “predicate device” already on the market.
This system creates a phenomenon known as “predicate creep.” For example, the GalaFLEX products used in many City of Selma “internal bra” procedures were cleared by claiming equivalence to surgical sutures. Because a suture is safe, the logic goes, a mesh made of the same material is also safe. This ignores the fact that a mesh has a vastly different surface-area-to-volume ratio and interacts with the immune system in a far more aggressive way than a single thread.
For our clients in City of Selma, we focus on the legal reality established in Medtronic v. Lohr, 518 U.S. 470 (1996): 510(k) clearance is not a finding of safety and effectiveness. It does not preempt state-law negligence and product liability claims. Because these devices never underwent the rigorous Premarket Approval (PMA) process required for higher-risk Class III devices, our firm can hold manufacturers like Becton Dickinson, Allergan, and MTF Biologics accountable for design defects and their failure to warn City of Selma surgeons and patients about the specific risks of breast application.
High Complication Rates and the “Red Breast” Phenomenon in Bexar County
The clinical literature reflects a stark contrast to the “safe and easy” marketing often presented to surgical candidates in City of Selma. Independent meta-analyses have shown that ADM-assisted breast reconstruction more than doubles the risk of infection compared to reconstructions performed without these materials. The pooled odds ratio for infection is 2.7, a statistic that manufacturers have contested but that the peer-reviewed record supports.
One of the most documented complications we see in City of Selma is Red Breast Syndrome (RBS). This is a non-infectious, sterile inflammation where the skin over the ADM becomes bright red and hot to the touch. Research led by Nguyen et al. (Aesthetic Surgery Journal, 2019) suggests this is an endotoxin-mediated response. Bacteria like E. coli have cell walls containing lipopolysaccharide (endotoxin). Even if the manufacturer “sterilizes” the ADM, the endotoxin survives. When implanted into a City of Selma patient, it triggers a massive inflammatory response.
If you are a City of Selma resident experiencing persistent redness, swelling, or “bottoming out” (where the implant moves too low because the scaffold failed), call Attorney911 at 1-888-288-9911. We speak the language of pathology and understand the difference between a routine surgical risk and a device-driven injury.
BIA-ALCL and BIA-SCC: The Cancer Risk for City of Selma Implant Patients
The most severe category of injury facing City of Selma patients involves two distinct malignancies associated with breast devices:
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
BIA-ALCL is a CD30-positive, ALK-negative T-cell lymphoma that develops in the fluid or scar tissue surrounding a textured implant. In July 2019, the FDA requested the global recall of the Allergan BIOCELL textured implant line because those devices were roughly six times more likely to cause BIA-ALCL than other textured products.
For a woman in City of Selma, the warning sign is typically a delayed seroma—a sudden, asymmetric swelling of the breast appearing seven to ten years after the original surgery. This is not a breast cancer in the traditional sense; it is a cancer of the immune system. We are closely monitoring the Allergan BIOCELL MDL 2921 in the District of New Jersey, where Judge Brian R. Martinotti has scheduled the first bellwether trials for October 19, 2026. This litigation will set the standard for compensation for thousands of women, including those in the City of Selma area.
Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC)
BIA-SCC is an even rarer but often more aggressive epithelial tumor. In March 2023, the FDA updated its safety communications to report on nineteen cases and three deaths documented in the literature. Unlike ALCL, BIA-SCC has been found in patients with both textured and smooth implants, and both saline and silicone. For the City of Selma patient, this diagnosis requires immediate, specialized surgical intervention, often including a total capsulectomy.
Texas Product Liability Law: What City of Selma Residents Must Know
Under the Texas Civil Practice and Remedies Code, product liability claims in City of Selma are governed by a strict two-year statute of limitations. This clock typically starts running from the date you discovered, or reasonably should have discovered, that your injury was caused by the defective device.
However, many manufacturers argue that the clock started when the FDA issued its 2023 labeling update for BD mesh products. We disagree. Many women in City of Selma were never notified of these updates by their surgeons or the hospital systems. We use the “Discovery Rule” to protect our clients, arguing that the statute of limitations should only begin when a woman in City of Selma receives a definitive diagnosis linking her symptoms to the mesh or scaffold.
Furthermore, Texas law imposes a fifteen-year statute of repose. If your device was first sold more than fifteen years ago, your right to sue may be extinguished regardless of when you were injured. This is why immediate action in City of Selma is so critical. Ralph Manginello and the team at Attorney911 can analyze your surgical records to determine if your claim is still viable under current Texas jurisprudence.
The Whistleblower: Dr. Hooman Noorchashm and the Fight for Truth
Our firm’s investigation into these devices is bolstered by the public record created by Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson, Dr. Noorchashm was terminated in 2022 after he internally raised safety concerns regarding the off-label marketing of GalaFLEX in breast cancer patients.
His allegations—recorded in a whistleblower lawsuit in New Jersey—include claims that BD withheld data on breast cancer recurrences in its GalaFLEX clinical trials and that hundreds of Manufacturer and User Facility Device Experience (MAUDE) reports were inadequately detailed. For a patient in City of Selma, this means the very data your surgeon used to decide the device was “safe” may have been incomplete or manipulated by corporate interests. We integrate this investigative authority into every case we file for our City of Selma clients.
Why a “Generalist” Firm in City of Selma Is Not Enough
Many personal injury firms in Bexar County handle car accidents or slip-and-falls. Defective medical device litigation is different. It requires a command of 21 CFR Part 803 (Medical Device Reporting) and the ability to survive a Daubert challenge regarding expert scientific testimony.
A generalist firm might file a complaint that gets dismissed under federal preemption because they didn’t know how to plead a “parallel claim”—a state-law claim that perfectly mirrors a federal requirement. Ralph Manginello and Lupe Peña have twenty-seven and thirteen years of experience respectively, focusing on complex liability. We are admitted to the Southern District of Texas and have the resources to take on the multi-billion-dollar legal teams representing device manufacturers.
Because we operate on a contingency fee basis, families in City of Selma never pay an hourly rate or upfront cost. We only get paid if we recover compensation for you. We also cover all the costs of litigation, including hiring top-tier pathology and regulatory experts to prove your case.
Step-by-Step Guide for City of Selma Residents Suspecting an Injury
If you are in City of Selma and suspect your breast mesh or ADM is failing, follow these steps immediately:
- Request Your Operative Reports: Contact the hospital or surgical center near City of Selma where your procedure was performed. You are legally entitled to your records. Look for the “Implant Log” or “Device Stickers” that list the brand, model, and lot number (UDI).
- Preserve the Evidence: If you require revision surgery in the City of Selma area, have your attorney send a “preservation of evidence” letter to the hospital. Any explanted mesh, ADM, or capsule tissue must be preserved for independent pathology—not just thrown away by the hospital as medical waste.
- Document Your Symptoms: Keep a journal of redness, pain, fluid drainage, or systemic issues like “Breast Implant Illness” symptoms (fatigue, brain fog, joint pain).
- Contact Attorney911: Call 1-888-ATTY-911 for a free case evaluation.
Frequently Asked Questions for City of Selma Candidates
Is surgical mesh approved by the FDA for breast surgery?
No. As of the FDA’s November 2023 letter to health care providers, no surgical mesh product is cleared or approved for breast procedures. Its use in City of Selma is entirely off-label.
What is the “internal bra” procedure I see advertised in City of Selma?
This is a marketing term for using a scaffold like GalaFLEX to support the lower part of the breast. While it sounds safe, the scaffolds can fail to dissolve or cause chronic inflammation.
Does my surgeon’s “learned intermediary” status protect the manufacturer?
Manufacturers often argue they only had a duty to warn the surgeon, not you. However, our firm argues that when a manufacturer promotes a device off-label in City of Selma, they lose that protection, as they gave the surgeon misleading information.
How much is a breast mesh case in City of Selma worth?
While every case is different, comparable mesh settlements for transvaginal or hernia injuries have reached into the six and seven figures. Factors include the number of revision surgeries and the severity of disfigurement.
Hablamos español?
Sí. Nuestra abogada Lupe Peña realiza consultas completas en español. No necesita un intérprete. Proporcionamos representación bilingüe directa para la comunidad de City of Selma.
Local Resources and Support for the City of Selma Community
We recognize that the legal side is only part of the journey for women in City of Selma. We encourage our neighbors to utilize the following independent resources (note: we do not endorse specific medical providers as they may be potential defendants):
- Susan G. Komen Breast Care Helpline: 1-877-465-6636 (Spanish available).
- FORCE (Facing Our Risk of Cancer Empowered): Supporting previvors and survivors in the City of Selma area with hereditary cancer concerns at facingourrisk.org.
- PROFILE Registry: The authoritative tracking for ALCL cases at ThePSF.org/PROFILE.
- SHARE Cancer Support: Providing peer support at 1-844-275-7427 with LatinaSHARE bilingual navigators.
Contact The Manginello Law Firm for a Free Consultation in City of Selma
You have endured enough surgery, enough pain, and enough uncertainty. If a defective biologic or synthetic device has cost you your health or your reconstruction in City of Selma, it is time to have a different kind of conversation.
Ralph Manginello and Lupe Peña are ready to listen. We combine the reach of a statewide powerhouse with the personal attention of a firm that knows City of Selma and Bexar County. We are currently reviewing cases of BIA-ALCL, BIA-SCC, severe infection, and device failure involving GalaFLEX, Phasix, AlloDerm, and FlexHD.
Call us today at 1-888-ATTY-911 or visit us at attorney911.com. We are the voice for City of Selma survivors. Past results do not guarantee future outcomes, but our commitment to aggressive, technical, and compassionate representation is constant. You pay nothing unless we win compensation for you.
The Manginello Law Firm, PLLC. Principal Office: 1177 West Loop South, Suite 1600, Houston, TX 77027. Serving City of Selma and all of Texas.
